BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, April 2, 2026
Home » Authors » Catherine Hollingsworth

Catherine Hollingsworth

Articles

ARTICLES

RegeneRx Secures $5M for Wound Healing Trials

Feb. 28, 2008
By Catherine Hollingsworth

Receptor Logic Finds Partner to Develop T-Cell Mimics

Feb. 28, 2008
By Catherine Hollingsworth

CollaGenex Being Acquired by Galderma for $420M Cash

Feb. 27, 2008
By Catherine Hollingsworth
CollaGenex Pharmaceuticals Inc. said it has agreed to be acquired by a U.S. affiliate of Galderma Pharma SA for about $420 million. (BioWorld Today)
Read More

CollaGenex Being Acquired by Galderma for $420M Cash

Feb. 27, 2008
By Catherine Hollingsworth
CollaGenex Pharmaceuticals Inc. said it has agreed to be acquired by a U.S. affiliate of Galderma Pharma SA for about $420 million. (BioWorld Today)
Read More

GTx Good News on ADT Gives its Stock a 36 Percent Boost

Feb. 26, 2008
By Catherine Hollingsworth

GTx Good News on ADT Gives its Stock a 36 Percent Boost

Feb. 26, 2008
By Catherine Hollingsworth

Repros' Preparing to Launch Phase III Studies of Proellex

Feb. 25, 2008
By Catherine Hollingsworth

Repros' Preparing to Launch Phase III Studies of Proellex

Feb. 25, 2008
By Catherine Hollingsworth

Affomix Closes $7M Series A for Automatic Antibody Effort

Feb. 22, 2008
By Catherine Hollingsworth

Affomix Closes $7M Series A for Automatic Antibody Effort

Feb. 22, 2008
By Catherine Hollingsworth
View All Articles by Catherine Hollingsworth

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 1, 2026.
  • Art concept for Parkinson's disease

    Emerging therapeutic strategies for Parkinson’s at ADPD 2026

    BioWorld
    Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
  • Vials, syringes, and pills

    With improved technologies, biomarkers, failed drugs may come into their own

    BioWorld
    At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
  • Comparison of neurons in a healthy brain and nerve cells in neurodegenerative disease with amyloid plaques

    Small-molecule TREM2 agonist advances to treat Alzheimer’s

    BioWorld Science
    Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 31, 2026
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing